Document is current
Any future updates will be listed below
-
Authors
Trentadue, Taylor P.
Thoreson, Andrew
Lopez, Cesar
Breighner, Ryan E.
Leng, Shuai
Kakar, Sanjeev
Rizzo, Marco
Zhao, Kristin D.
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (F31 AR082227, R01 AR071338, T32 AR056950)
National Institute of General Medical Sciences (T32 GM065841, T32 GM145408)
- License Information
-
More Information
Article History
Received: 4 November 2024
Revised: 17 December 2024
Accepted: 29 December 2024
First Online: 5 February 2025
Declarations
:
: This study was approved by the Institutional Review Board at the Mayo Clinic (IRB 20–007668).
: Work was performed at the Mayo Clinic, Rochester, Minnesota.
: The authors acknowledge multiple funding sources. REB holds a consulting contract with Stryker Corporation. SK receives royalties from Arthrex. The authors declare no other known conflicts of interest with respect to the research, authorship, and/or publication of this article.
: All participants provided written informed consent prior to participation.
: During written informed consenting, participants were informed that de-identified results of the research study may be made public (for example, through scientific meetings, reports, or media).
